Guest Edited Collection: Epigenetics Within the Tumor Microenvironment

Overview

Journal Sci Rep

Specialty Science

Date 2022 Sep 6

PMID 36064963

Authors

Aamir Ahmad

Affiliations

Soon will be listed here.

Citing Articles

VIM-AS1, which is regulated by CpG methylation, cooperates with IGF2BP1 to inhibit tumor aggressiveness via EPHA3 degradation in hepatocellular carcinoma.

Han S, Ko J, Jung S, Oh S, Kim D, Kang E Exp Mol Med. 2024; 56(12):2617-2630.

PMID: 39617786 PMC: 11671536. DOI: 10.1038/s12276-024-01352-6.

Corruptive Reprograming of Macrophages into Tumor-Associated Macrophages: The Transcriptional, Epigenetic and Metabolic Basis.

Ahmad A Cancers (Basel). 2023; 15(17).

PMID: 37686567 PMC: 10487138. DOI: 10.3390/cancers15174291.

References

Wang Y, Janku F, Piha-Paul S, Hess K, Broaddus R, Liu L . Phase I studies of vorinostat with ixazomib or pazopanib imply a role of antiangiogenesis-based therapy for TP53 mutant malignancies. Sci Rep. 2020; 10(1):3080. PMC: 7033174. DOI: 10.1038/s41598-020-58366-z. View

Calhoun M, Cui Y, Elliott E, Mo X, Otero J, Winter J . MicroRNA-mRNA Interactions at Low Levels of Compressive Solid Stress Implicate mir-548 in Increased Glioblastoma Cell Motility. Sci Rep. 2020; 10(1):311. PMC: 6962377. DOI: 10.1038/s41598-019-56983-x. View

Dalhat M, Altayb H, Imran Khan M, Choudhry H . Structural insights of human N-acetyltransferase 10 and identification of its potential novel inhibitors. Sci Rep. 2021; 11(1):6051. PMC: 7960695. DOI: 10.1038/s41598-021-84908-0. View

Miyata S, Tominaga K, Sakashita E, Urabe M, Onuki Y, Gomi A . Comprehensive Metabolomic Analysis of IDH1 Clinical Glioma Samples Reveals Suppression of β-oxidation Due to Carnitine Deficiency. Sci Rep. 2019; 9(1):9787. PMC: 6611790. DOI: 10.1038/s41598-019-46217-5. View

Mitsui E, Yoshida S, Shinoda Y, Matsumori Y, Tsujii H, Tsuchida M . Identification of ryuvidine as a KDM5A inhibitor. Sci Rep. 2019; 9(1):9952. PMC: 6616564. DOI: 10.1038/s41598-019-46346-x. View

Xavier P, Cordeiro Y, Alexandre P, Pires P, Saranholi B, Silva E . An epigenetic screening determines BET proteins as targets to suppress self-renewal and tumorigenicity in canine mammary cancer cells. Sci Rep. 2019; 9(1):17363. PMC: 6874531. DOI: 10.1038/s41598-019-53915-7. View

van der Vos K, Vis D, Nevedomskaya E, Kim Y, Choi W, McConkey D . Epigenetic profiling demarcates molecular subtypes of muscle-invasive bladder cancer. Sci Rep. 2020; 10(1):10952. PMC: 7331601. DOI: 10.1038/s41598-020-67850-5. View

Kashima Y, Togashi Y, Fukuoka S, Kamada T, Irie T, Suzuki A . Potentiality of multiple modalities for single-cell analyses to evaluate the tumor microenvironment in clinical specimens. Sci Rep. 2021; 11(1):341. PMC: 7801605. DOI: 10.1038/s41598-020-79385-w. View

Gajewski T, Schreiber H, Fu Y . Innate and adaptive immune cells in the tumor microenvironment. Nat Immunol. 2013; 14(10):1014-22. PMC: 4118725. DOI: 10.1038/ni.2703. View

10.

Ahmad A . Epigenetic regulation of immunosuppressive tumor-associated macrophages through dysregulated microRNAs. Semin Cell Dev Biol. 2021; 124:26-33. DOI: 10.1016/j.semcdb.2021.09.001. View

11.

Haque A, Moriyama M, Kubota K, Ishiguro N, Sakamoto M, Chinju A . CD206 tumor-associated macrophages promote proliferation and invasion in oral squamous cell carcinoma via EGF production. Sci Rep. 2019; 9(1):14611. PMC: 6787225. DOI: 10.1038/s41598-019-51149-1. View

12.

Oshi M, Tokumaru Y, Asaoka M, Yan L, Satyananda V, Matsuyama R . M1 Macrophage and M1/M2 ratio defined by transcriptomic signatures resemble only part of their conventional clinical characteristics in breast cancer. Sci Rep. 2020; 10(1):16554. PMC: 7538579. DOI: 10.1038/s41598-020-73624-w. View

13.

Ren W, Zhang X, Li W, Feng Q, Feng H, Tong Y . Circulating and tumor-infiltrating arginase 1-expressing cells in gastric adenocarcinoma patients were mainly immature and monocytic Myeloid-derived suppressor cells. Sci Rep. 2020; 10(1):8056. PMC: 7229115. DOI: 10.1038/s41598-020-64841-4. View

14.

Ahmad A . Non-coding RNAs: A tale of junk turning into treasure. Noncoding RNA Res. 2018; 1(1):1-2. PMC: 6096404. DOI: 10.1016/j.ncrna.2016.12.001. View

15.

Mohamed R, Abu-Shahba N, Mahmoud M, Abdelfattah A, Zakaria W, ElHefnawi M . Co-regulatory Network of Oncosuppressor miRNAs and Transcription Factors for Pathology of Human Hepatic Cancer Stem Cells (HCSC). Sci Rep. 2019; 9(1):5564. PMC: 6447552. DOI: 10.1038/s41598-019-41978-5. View

16.

Gao Y, Zhang W, Liu C, Li G . miR-200 affects tamoxifen resistance in breast cancer cells through regulation of MYB. Sci Rep. 2019; 9(1):18844. PMC: 6906507. DOI: 10.1038/s41598-019-54289-6. View

17.

Zhang X, Li Y, Ma H, Gao Y . Regulation of MYB mediated cisplatin resistance of ovarian cancer cells involves miR-21-wnt signaling axis. Sci Rep. 2020; 10(1):6893. PMC: 7181810. DOI: 10.1038/s41598-020-63396-8. View

18.

Li X, Shen W, Jin X, Ren P, Zhang J . Let-7c regulated epithelial-mesenchymal transition leads to osimertinib resistance in NSCLC cells with EGFR T790M mutations. Sci Rep. 2020; 10(1):11236. PMC: 7343825. DOI: 10.1038/s41598-020-67908-4. View

19.

Tian D, Tian M, Ma Z, Zhang L, Cui Y, Li J . Anesthetic propofol epigenetically regulates breast cancer trastuzumab resistance through IL-6/miR-149-5p axis. Sci Rep. 2020; 10(1):8858. PMC: 7264192. DOI: 10.1038/s41598-020-65649-y. View

20.

Sun L, Tian D, Yang Z, Li J . Exosomal miR-21 promotes proliferation, invasion and therapy resistance of colon adenocarcinoma cells through its target PDCD4. Sci Rep. 2020; 10(1):8271. PMC: 7237414. DOI: 10.1038/s41598-020-65207-6. View